Treatment of hypertension in children and adolescents
- PMID: 17690916
- PMCID: PMC2756388
- DOI: 10.1007/s00467-007-0573-4
Treatment of hypertension in children and adolescents
Abstract
The treatment of hypertension in children and adolescents has been markedly changed in recent years by several factors, including the publication of new consensus recommendations, the obesity epidemic, and the increased availability of information on efficacy and safety of antihypertensive medications in the young. In this review we present an updated approach to the outpatient management of hypertension in the child or adolescent, utilizing representative cases to illustrate important principles as well as possible controversies.
Figures
Similar articles
-
Evaluation and Management of Stage 2 Hypertension in Pediatric Patients.Curr Hypertens Rep. 2018 Jul 6;20(9):73. doi: 10.1007/s11906-018-0873-z. Curr Hypertens Rep. 2018. PMID: 29980866 Review.
-
Hypertension in Children and Adolescents.Adv Chronic Kidney Dis. 2019 Mar;26(2):146-150. doi: 10.1053/j.ackd.2019.02.003. Adv Chronic Kidney Dis. 2019. PMID: 31023449 Review.
-
High Blood Pressure in Children and Adolescents.Am Fam Physician. 2018 Oct 15;98(8):486-494. Am Fam Physician. 2018. PMID: 30277729
-
Management of hypertension in the young: role of antihypertensive medications.J Cardiovasc Pharmacol. 2011 Aug;58(2):111-20. doi: 10.1097/FJC.0b013e31820d1b89. J Cardiovasc Pharmacol. 2011. PMID: 21242810 Review.
-
Diagnosis and treatment of stage 1 hypertension: which guidelines should we follow?J Am Soc Hypertens. 2014 May;8(5):358-9. doi: 10.1016/j.jash.2014.02.005. Epub 2014 Feb 21. J Am Soc Hypertens. 2014. PMID: 24726949 No abstract available.
Cited by
-
Pharmacologic Management of Pediatric Hypertension.Paediatr Drugs. 2016 Feb;18(1):31-43. doi: 10.1007/s40272-015-0151-3. Paediatr Drugs. 2016. PMID: 26597490 Review.
-
Primary versus secondary hypertension in children followed up at an outpatient tertiary unit.Pediatr Nephrol. 2011 Mar;26(3):441-7. doi: 10.1007/s00467-010-1712-x. Epub 2010 Dec 21. Pediatr Nephrol. 2011. PMID: 21174218
-
Management of hypertension in children with cardiovascular disease and heart failure.Int J Prev Med. 2014 Mar;5(Suppl 1):S10-6. Int J Prev Med. 2014. PMID: 24791185 Free PMC article. Review.
-
Antihypertensive drug use by children: are the drugs labeled and indicated?J Clin Hypertens (Greenwich). 2012 Jun;14(6):388-95. doi: 10.1111/j.1751-7176.2012.00656.x. Epub 2012 May 7. J Clin Hypertens (Greenwich). 2012. PMID: 22672093 Free PMC article.
-
Blood pressure variability, prehypertension, and hypertension in adolescents.Adolesc Health Med Ther. 2012 May 7;3:43-50. doi: 10.2147/AHMT.S15942. eCollection 2012. Adolesc Health Med Ther. 2012. PMID: 24600286 Free PMC article. Review.
References
-
- Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr, Jones DW, Materson BJ, Oparil S, Wright JT, Jr, Roccella EJ, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute. National High Blood Pressure Education Program Coordinating Committee The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. J Am Med Assoc. 2003;289:2560–2572. - PubMed
-
- National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2005) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. National heart, lung, and blood institute, Bethesda, Maryland. National institute of health, NIH publication 05:5267
-
- Stergiou GS, Yiannes NJ, Rarra VC, Alamara CV. White-coat hypertension and masked hypertension in children. Blood Press Monit. 2005;10:297–300. - PubMed
-
- Flynn JT, Daniels SR. Pharmacologic treatment of hypertension in children and adolescents. J Pediatr. 2006;149:746–754. - PubMed
-
- ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) J Am Med Assoc. 2002;288:2981–2997. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical